BioCryst Pharmaceuticals, Inc.

BCRXNASDAQHealthcareDrug Manufacturers - Specialty & Generic

$8.02- (-)1Y +19.35%

As of Oct 15, 2026 close

Market cap: $2.13B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $6.23$11.22
Volume (live): -
Avg. volume (3M): 5.26M

BioCryst Pharmaceuticals, Inc. (BCRX) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for BioCryst Pharmaceuticals, Inc. stock.

Analyst Consensus Rating

Investment consensus from 10 professional research analysts

Consensus Rating

Buy

Based on 10 unique analysts

(12 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$19.25

+140.02% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest BCRX Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 9, 2026	Tazeen Ahmad	BofA Securities	Reiterates	Buy	$15.00
Oct 9, 2026	Brian Abrahams	RBC Capital	Maintains	Hold	$11.00
Sep 30, 2026	Jessica Fye	JP Morgan	Reiterates	Hold	$12.00 → $13.00 +1.00 (+8.3%)
Sep 18, 2026	Sundeep Ganoria	Zacks Equity Research	Initiates Coverage	Hold	-
Sep 10, 2026	Brian Abrahams	RBC Capital	Downgrades	Hold	$13.00 → $11.00 −2.00 (−15.4%)
Sep 8, 2026	Serge Belanger	Needham	Maintains	Buy	$16.00
Aug 29, 2026	Zacks Equity Research	Zacks Equity Research	Initiates Coverage	Buy	-
Aug 10, 2026	Unknown Analyst	Evercore ISI Group	Maintains	Buy	$17.00
Aug 6, 2026	Laura Chico	Wedbush	Maintains	Buy	$20.00
Aug 6, 2026	Andrew Fein	HC Wainwright	Maintains	Buy	$32.00
Aug 6, 2026	Stacy Ku	TD Cowen	Maintains	Buy	$30.00
Aug 5, 2026	Stacy Ku	TD Cowen	Maintains	Buy	$30.00

Tazeen Ahmad

BofA Securities

BuyReiterates

$15.00

Oct 9

Brian Abrahams

RBC Capital

HoldMaintains

$11.00

Oct 9

Jessica Fye

JP Morgan

HoldReiterates

$12.00 → $13.00

Sep 30

Sundeep Ganoria

Zacks Equity Research

HoldInitiates Coverage

Sep 18

Brian Abrahams

RBC Capital

HoldDowngrades

$13.00 → $11.00

Sep 10

Serge Belanger

Needham

BuyMaintains

$16.00

Sep 8

Zacks Equity Research

BuyInitiates Coverage

Aug 29

Unknown Analyst

Evercore ISI Group

BuyMaintains

$17.00

Aug 10

Laura Chico

Wedbush

BuyMaintains

$20.00

Aug 6

Andrew Fein

HC Wainwright

BuyMaintains

$32.00

Aug 6

Stacy Ku

TD Cowen

BuyMaintains

$30.00

Aug 6

Stacy Ku

TD Cowen

BuyMaintains

$30.00

Aug 5

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 9, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for BCRX?

The analyst consensus rating for BCRX is Buy, based on the latest ratings from 10 analysts over the last 90 days.

What is the average price target for BCRX?

The average 12-month price target for BCRX is $19.25, representing an upside of 140.0% from the Oct 15, 2026 close of $8.02.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.